Related Experiment Video
Updated: Aug 12, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
Monoamine oxidase inhibitors: reappraisal of dietary considerations
Abstract:
Dangers of adverse effects with MAOIs have been exaggerated, the most serious being hypertensive interactions with cheeses, yeast extracts, certain alcoholic beverages, broad bean pods, certain meats, and foods that are unfresh or overripe. Some adverse reactions involving MAOI-diet interactions were likely due to migraine headache, consumption of unusually large quantities of low-tyramine-containing foods, or other individual variations. Since MAOIs have advantages in pharmacotherapy of certain depressive subtypes and anxiety states, knowledge of the dietary considerations with MAOI treatment is essential to both the clinician and their patients. Patients are easily educated about MAOIs and the necessary dietary restrictions using the steps outlined in this report. Finally, written information concerning the MAOI diet together with Medic-Alert emblems or drug manufacturers' cards warning of MAOI-drug interactions should be provided before MAOI treatment is begun. Although MAOI-drug interactions were not addressed in this article, in general, it is good policy for the patient to contact the clinician whenever another medication (over-the-counter or prescribed by another physician) is at issue so that its safety can be verified.
More Related Videos
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents